Skip to main content
Top
Literature
2.
go back to reference van Alfen N, Sinke RJ, Zwarts MJ, Gabreels-Festen A, Praamstra P, Kremer BP, Horstink MW (2001) Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 49:805–807CrossRefPubMed van Alfen N, Sinke RJ, Zwarts MJ, Gabreels-Festen A, Praamstra P, Kremer BP, Horstink MW (2001) Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 49:805–807CrossRefPubMed
3.
go back to reference van Schaik IN, Jobsis GJ, Vermeulen M, Keizers H, Bolhuis PA, de Visser M (1997) Machado-Joseph disease presenting as severe asymmetric proximal neuropathy. J Neurol Neurosurg Psychiatry 63:534–536CrossRefPubMedPubMedCentral van Schaik IN, Jobsis GJ, Vermeulen M, Keizers H, Bolhuis PA, de Visser M (1997) Machado-Joseph disease presenting as severe asymmetric proximal neuropathy. J Neurol Neurosurg Psychiatry 63:534–536CrossRefPubMedPubMedCentral
4.
go back to reference Elden AC, Kim H, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rüb U, Auburger G, Trojanowski JQ, Lee VMY, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069–1075CrossRefPubMedPubMedCentral Elden AC, Kim H, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rüb U, Auburger G, Trojanowski JQ, Lee VMY, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069–1075CrossRefPubMedPubMedCentral
5.
go back to reference Lee T, Li YR, Gitler AD, Chesi A, Hart MP, Ramos D, Jethava N, Hosangadi D, Epstein J, Hodges B, Bonini NM (2011) Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 76:2062–2065CrossRefPubMedPubMedCentral Lee T, Li YR, Gitler AD, Chesi A, Hart MP, Ramos D, Jethava N, Hosangadi D, Epstein J, Hodges B, Bonini NM (2011) Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 76:2062–2065CrossRefPubMedPubMedCentral
6.
go back to reference Conforti FL, Spataro R, Muglia M, Rodolico C, Valentino P, Bono F, Colletti T, Monsurro MR, Gambardella A, La Bella V, Sproviero W, Mazzei R, Cavalcanti F, Condino F, Simone IL, Logroscino G, Patitucci A, Magariello A (2012) Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 79:2315–2320CrossRefPubMed Conforti FL, Spataro R, Muglia M, Rodolico C, Valentino P, Bono F, Colletti T, Monsurro MR, Gambardella A, La Bella V, Sproviero W, Mazzei R, Cavalcanti F, Condino F, Simone IL, Logroscino G, Patitucci A, Magariello A (2012) Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 79:2315–2320CrossRefPubMed
7.
go back to reference Brenner D, Müller K, Gastl R, Gorges M, Otto M, Pinkhardt EH, Kassubek J, Weishaupt JH, Ludolph AC (2019) Analysis of CACNA1A CAG repeat lengths in patients with familial ALS. Neurobiol Aging 74:235CrossRefPubMed Brenner D, Müller K, Gastl R, Gorges M, Otto M, Pinkhardt EH, Kassubek J, Weishaupt JH, Ludolph AC (2019) Analysis of CACNA1A CAG repeat lengths in patients with familial ALS. Neurobiol Aging 74:235CrossRefPubMed
Metadata
Title
Prominent lower motor neuron involvement in patients with intermediate-length CAG repeats in ATXN3 gene
Authors
Siqi Dong
Dongqing Zhu
Wenbo Yang
Jiatong Li
Xiangjun Chen
Publication date
23-08-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 12/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06325-z

Other articles of this Issue 12/2022

Neurological Sciences 12/2022 Go to the issue